Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali McBride

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
American Health & Drug Benefits|July 4, 2014
Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims AnalysisClaudio Faria, Xuan Li, Norman Nagl, et al.
Journal of Medical Economics|May 18, 2021
Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancerAli McBride, Karen MacDonald, Adolfo Fuentes-Alburo, et al.
Hospital Pharmacy|December 6, 2014
Formulary Selection Criteria for Biosimilars: Considerations for US Health-System PharmacistsNiesha Griffith, Ali McBride, James G Stevenson, et al.
Journal of Medical Economics|April 19, 2021
Conversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatmentAli McBride, Karen MacDonald, Adolfo Fuentes-Alburo, et al.
Journal of the American Pharmacists Association : Japha|November 27, 2022
Pharmacist biosimilar survey reveals knowledge gapsJames G Stevenson, Dorothy McCabe, Melissa McGrath, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 2, 2012
Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemiaAli McBride, Kristan M Augustin, Julie Nobbe, et al.
Advances in Radiation Oncology|March 21, 2018
Pentoxifylline and vitamin E drug compliance after adjuvant breast radiation therapyJustin M Famoso, Brady Laughlin, Ali McBride, et al.
Blood and Lymphatic Cancer : Targets and Therapy|November 30, 2023
Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive ReviewNada Alsuhebany, Congshan Pan, Eileen Holovac, et al.
Transplantation and Cellular Therapy|March 30, 2022
Health Care Resource Utilization and Total Costs of Care Among Patients with Diffuse Large B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy in the United StatesScott J Keating, Tao Gu, Monika P Jun, et al.
Journal of Pharmacy Practice|May 3, 2012
Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literatureAli McBride, Scott J Antonia, Eric B Haura, et al.
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
American Health & Drug Benefits|July 4, 2014
Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims AnalysisClaudio Faria, Xuan Li, Norman Nagl, et al.
Journal of Medical Economics|May 18, 2021
Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancerAli McBride, Karen MacDonald, Adolfo Fuentes-Alburo, et al.
Hospital Pharmacy|December 6, 2014
Formulary Selection Criteria for Biosimilars: Considerations for US Health-System PharmacistsNiesha Griffith, Ali McBride, James G Stevenson, et al.
Journal of Medical Economics|April 19, 2021
Conversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatmentAli McBride, Karen MacDonald, Adolfo Fuentes-Alburo, et al.
Journal of the American Pharmacists Association : Japha|November 27, 2022
Pharmacist biosimilar survey reveals knowledge gapsJames G Stevenson, Dorothy McCabe, Melissa McGrath, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 2, 2012
Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemiaAli McBride, Kristan M Augustin, Julie Nobbe, et al.
Advances in Radiation Oncology|March 21, 2018
Pentoxifylline and vitamin E drug compliance after adjuvant breast radiation therapyJustin M Famoso, Brady Laughlin, Ali McBride, et al.
Blood and Lymphatic Cancer : Targets and Therapy|November 30, 2023
Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive ReviewNada Alsuhebany, Congshan Pan, Eileen Holovac, et al.
Transplantation and Cellular Therapy|March 30, 2022
Health Care Resource Utilization and Total Costs of Care Among Patients with Diffuse Large B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy in the United StatesScott J Keating, Tao Gu, Monika P Jun, et al.
Journal of Pharmacy Practice|May 3, 2012
Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literatureAli McBride, Scott J Antonia, Eric B Haura, et al.
Pageof 15